Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Elysee Development (PK) Charts. Click Here for more Elysee Development (PK) Charts.](/p.php?pid=staticchart&s=NO%5EASXSF&p=8&t=15)
Remedent, Inc. (OTC BB: REMI) a leader in the research and development,
manufacturing and marketing of oral care and cosmetic dentistry
products, will release a business update and guidance for the remainder
of the year and 2007 on Wednesday, October 4, 2006.
Management of Remedent will host a conference call the same day at 10
a.m. EDT. The call will include comments about the progress of its
business and provide guidance for the next 12-15 months. Those who wish
to participate in the call may telephone 888-335-6674, (U.S.), or
973-935-2981, (international callers), passcode #7935948 approximately
15 minutes before the 10 a.m. EST starting time. If you cannot
participate in the call, but wish to listen to it, you may login at
Remedent’s website at www.remedent.com.
You will be able to listen by either Windows Media or Real Player
approximately 2 hours after the completion of the call.
About Remedent:
Remedent, Inc. strives to be a world leader in the research and
development, manufacturing and marketing of oral care and cosmetic
dentistry products. Remedent products are renowned for their
technological superiority and ease-of-use. Based in Deurle, Belgium and
El Segundo, CA, Remedent has successfully researched, developed and
manufactured all of its own products. These products are now distributed
in more than 35 countries worldwide. Remedent consists of two divisions:
one that serves the dental community and one that is focused on the
over-the-counter consumer market. Visit www.remedent.com
for further information.
Certain matters discussed in this press release are "forward-looking
statements" intended to qualify for the safe harbors from liability
established by the Private Securities Litigation Reform Act of 1995. In
particular, the Company's statements regarding trends in the marketplace
and potential future results are examples of such forward-looking statements.
The forward-looking statements include risks and uncertainties,
including, but not limited to, the consummation and the successful
integration of proposed acquisitions, the timing of projects due to the
variability in size, scope and duration of projects, estimates made by
management with respect to the Company's financial results, backlog,
critical accounting policies, regulatory delays, clinical study results
which lead to reductions or cancellations of projects, and other
factors, including general economic conditions and regulatory
developments, not within the Company's control. The factors
discussed herein and expressed from time to time in the Company's
filings with the Securities and Exchange Commission could cause actual
results and developments to be materially different from those expressed
in or implied by such statements. The forward-looking statements
are made only as of the date of this press release and the Company
undertakes no obligation to publicly update such forward-looking statements
to reflect subsequent events or circumstance.
Remedent, Inc. (OTC BB: REMI) a leader in the research and
development, manufacturing and marketing of oral care and cosmetic
dentistry products, will release a business update and guidance for
the remainder of the year and 2007 on Wednesday, October 4, 2006.
Management of Remedent will host a conference call the same day at
10 a.m. EDT. The call will include comments about the progress of its
business and provide guidance for the next 12-15 months. Those who
wish to participate in the call may telephone 888-335-6674, (U.S.), or
973-935-2981, (international callers), passcode #7935948 approximately
15 minutes before the 10 a.m. EST starting time. If you cannot
participate in the call, but wish to listen to it, you may login at
Remedent's website at www.remedent.com. You will be able to listen by
either Windows Media or Real Player approximately 2 hours after the
completion of the call.
About Remedent:
Remedent, Inc. strives to be a world leader in the research and
development, manufacturing and marketing of oral care and cosmetic
dentistry products. Remedent products are renowned for their
technological superiority and ease-of-use. Based in Deurle, Belgium
and El Segundo, CA, Remedent has successfully researched, developed
and manufactured all of its own products. These products are now
distributed in more than 35 countries worldwide. Remedent consists of
two divisions: one that serves the dental community and one that is
focused on the over-the-counter consumer market. Visit
www.remedent.com for further information.
Certain matters discussed in this press release are
"forward-looking statements" intended to qualify for the safe harbors
from liability established by the Private Securities Litigation Reform
Act of 1995. In particular, the Company's statements regarding trends
in the marketplace and potential future results are examples of such
forward-looking statements. The forward-looking statements include
risks and uncertainties, including, but not limited to, the
consummation and the successful integration of proposed acquisitions,
the timing of projects due to the variability in size, scope and
duration of projects, estimates made by management with respect to the
Company's financial results, backlog, critical accounting policies,
regulatory delays, clinical study results which lead to reductions or
cancellations of projects, and other factors, including general
economic conditions and regulatory developments, not within the
Company's control. The factors discussed herein and expressed from
time to time in the Company's filings with the Securities and Exchange
Commission could cause actual results and developments to be
materially different from those expressed in or implied by such
statements. The forward-looking statements are made only as of the
date of this press release and the Company undertakes no obligation to
publicly update such forward-looking statements to reflect subsequent
events or circumstance.